Case Study

Hummingbird Bioscience

  • Geller Biopharm was retained to work with Hummingbird Bioscience as its exclusive financial advisor to manage a $100M C round in winter of 2021
  • Initial work entailed helping to position the company for institutional investors: assisting in building appropriate materials including, PowerPoint presentation and online data room.
  • Arranged over 100 meetings with US, ex-US, and global institutional investors including, venture and crossover funds
  • Assisted in finalizing and completing an upsized, several times oversubscribed, $125M financing
  • Negotiated a two tranche transaction where both tranches were completed
  • This case study demonstrates our ability to successfully complete a large transaction for a company with strong science and management.
  • Past performance is not a guarantee of future results
Geller Biopharm

  Broker / Dealer services provided by Pickwick Capital Partners, LLC. Member FINRA / SIPC

Download our presentation

Get a digital copy of our PDF presentation

Download PDF